组织芯片，组织微阵列

FDA808ci-2	多器官肿瘤及边缘器官组织组合芯片，附病理分级、TNM和临床分期，72例/72点
点数	72	例数	72
行数	8	列数	9
点直径(mm)	1.5	厚度(µm)	5.0
组织阵列类型	石蜡包埋	种属	人类
QA/QC	H&E and IHC confirmed
Applications	Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes	1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better. 2.Bake the slides for 30 minutes at 60℃ before the experiment; 3.Please choose a gentle repair method to avoid tissue detachment.

Legend:

Smo

-Smooth muscle

Ret

-Retroperitoneum

Bon

-Bone

Bla

-Bladder

Pel

-Pelvic cavity

Lym

-Lymph node

Med

-Mediastinum

Abd

-Abdominal cavity

Bac

-Back

Ski

-Skin

Rec

-Rectum

Str

-Striated muscle

Ute

-Uterine cervix

Ute

-Uterus

Pro

-Prostate

Kid

-Kidney

Liv

-Liver

Col

-Colon

Int

-Intestine

Sto

-Stomach

Eso

-Esophagus

Lun

-Lung

Spl

-Spleen

Bre

-Breast

Thy

-Thyroid

Tes

-Testis

Pan

-Pancreas

Ova

-Ovary

Cer

-Cerebrum

Car

-Cardiac pericardium

Ner

-Nerve

Ske

-Skeletal muscle

Malignant (*)

Malignant (0.0)

Malignant (I)

Malignant (IA)

Malignant (IB)

Malignant (IB G1)

Malignant (II)

Malignant (IIA)

Malignant (IIB)

Malignant (IIB G2)

Malignant (III)

Malignant (IIIA)

Malignant (IIIB)

Malignant (IIIB G3)

Malignant (IV)

NAT (*)

Normal (*)

TISSUE ARRAYS FDA808ci-2

	1	2	3	4	5	6	7	8	9
A	UTE	UTE	UTE	UTE	UTE	UTE	SKE	SKE	SKE
B	SKI	SKI	SKI	NER	NER	NER	LUN	CAR	LUN
C	CER	CER	CER	CER	OVA	OVA	PAN	PAN	TES
D	TES	THY	THY	BRE	BRE	BRE	SPL	LUN	LUN
E	LUN	ESO	ESO	STO	INT	INT	COL	COL	REC
F	REC	LIV	LIV	KID	PRO	PRO	UTE	UTE	UTE
G	UTE	UTE	STR	REC	SKI	SKI	BAC	RET	ABD
H	MED	LYM	LYM	PEL	BLA	BLA	BON	RET	SMO

Pos	No	Age	Sex	Organ_Anatomic_Site	Pathology_diagnosis	Grade	TNM	Stage	Type	isBackUp
A1	1	21	F	Uterus	Adenomatoid hyperplasia of endometrium	*	*	*	Normal	N
A2	2	21	F	Uterus	Normal endometrium tissue	*	*	*	Normal	N
A3	3	18	F	Uterus	Normal endometrium tissue	*	*	*	Normal	N
A4	4	35	F	Uterine cervix	Cancer adjacent cervical canals tissue (hyperplasia)	*	*	*	NAT	N
A5	5	72	F	Uterine cervix	Cancer adjacent cervix tissue with saccular ectasia	*	*	*	NAT	N
A6	6	65	F	Uterine cervix	Cancer adjacent cervix tissue	*	*	*	NAT	N
A7	7	21	F	Skeletal muscle	Normal skeletal muscle tissue	*	*	*	Normal	N
A8	8	49	F	Skeletal muscle	Cancer adjacent skeletal muscle tissue	*	*	*	NAT	N
A9	9	47	M	Skeletal muscle	Normal skeletal muscle tissue	*	*	*	Normal	N
B1	10	50	F	Skin	Cancer adjacent skin tissue	*	*	*	NAT	N
B2	11	37	M	Skin	Normal skin tissue	*	*	*	Normal	N
B3	12	18	F	Skin	Normal skin tissue of head	*	*	*	Normal	N
B4	13	33	M	Nerve	Normal peripheral nerve tissue	*	*	*	Normal	N
B5	14	35	M	Nerve	Normal peripheral nerve tissue	*	*	*	Normal	N
B6	15	35	M	Nerve	Normal peripheral nerve tissue	*	*	*	Normal	N
B7	16	22	M	Lung	Normal mesothelial tissue	*	*	*	Normal	N
B8	17	27	F	Cardiac pericardium	Normal mesothelial tissue	*	*	*	Normal	N
B9	18	47	M	Lung	Normal lung and mesothelium tissue	*	*	*	Normal	N
C1	19	41	F	Cerebrum	Glioblastoma	3--4	*	*	Malignant	N
C2	20	65	F	Cerebrum	Atypical meningioma	*	*	*	Malignant	N
C3	21	15	F	Cerebrum	Malignant ependymoma	*	*	*	Malignant	N
C4	22	39	F	Cerebrum	Oligodendroglioma	2	*	*	Malignant	N
C5	23	63	F	Ovary	Serous adenocarcinoma	3	T2N0M0	II	Malignant	N
C6	24	29	F	Ovary	Adenocarcinoma	2	T3N0M0	III	Malignant	N
C7	25	12	F	Pancreas	Islet cell tumor	*	*	*	Malignant	N
C8	26	64	M	Pancreas	Adenocarcinoma	2	T3N0M0	II	Malignant	N
C9	27	32	M	Testis	Seminoma	*	T1N0M0	I	Malignant	N
D1	28	30	M	Testis	Embryonal carcinoma	*	T2N0M0	I	Malignant	N
D2	29	33	F	Thyroid	Medullary carcinoma	*	T3N0M0	II	Malignant	N
D3	30	46	F	Thyroid	Papillary carcinoma	*	T4N0M0	III	Malignant	N
D4	31	43	F	Breast	Invasive ductal carcinoma	1	T2N1M0	IIA	Malignant	N
D5	32	48	F	Breast	Intraductal carcinoma	*	TisN0M0	0.0	Malignant	N
D6	33	58	F	Breast	Invasive ductal carcinoma	1--2	T2N1M0	IIB	Malignant	N
D7	34	21	M	Spleen	Diffuse B-cell lymphoma	*	*	*	Malignant	N
D8	35	61	M	Lung	Small cell undifferentiated carcinoma	*	T2N0M0	I	Malignant	N
D9	36	66	M	Lung	Squamous cell carcinoma	3	T2N0M0	I	Malignant	N
E1	37	42	M	Lung	Adenocarcinoma	2--3	T2N0M0	IB	Malignant	N
E2	38	67	M	Esophagus	Neuroendocrine carcinoma	*	T2N1M0	IIA	Malignant	N
E3	39	63	M	Esophagus	Adenocarcinoma	3	T3N0M0	IIA	Malignant	N
E4	40	73	F	Stomach	Signet-ring cell carcinoma	*	T2N1M0	II	Malignant	N
E5	41	64	F	Intestine	Adenocarcinoma	3	T4N0M0	II	Malignant	N
E6	42	71	F	Intestine	Stromal sarcoma	*	T2N0M0	IIB G2	Malignant	N
E7	43	72	F	Colon	Adenocarcinoma	1	T4N0M0	IIB	Malignant	N
E8	44	54	M	Colon	Interstitialoma	*	T2N0M0	IIB G2	Malignant	N
E9	45	36	M	Rectum	Adenocarcinoma	2	T2N0M0	I	Malignant	N
F1	46	63	F	Rectum	Moderate malignant interstitialoma	*	T2N0M0	IIB G2	Malignant	N
F2	47	55	F	Liver	Hepatocellular carcinoma	1--2	T3N0M0	IIIA	Malignant	N
F3	48	17	F	Liver	Hepatoblastoma	*	*	*	Malignant	N
F4	49	60	M	Kidney	Clear cell carcinoma	1	T2N0M0	II	Malignant	N
F5	50	80	M	Prostate	Adenocarcinoma (Gleason grade:4 Gleason score:4+5)	3	T4N1M1c	IV	Malignant	N
F6	51	77	M	Prostate	Adenocarcinoma (Gleason grade:3 Gleason score:3+4)	2--3	T2N0M0	II	Malignant	N
F7	52	33	F	Uterus	Leiomyoma	*	T2N0M0	IB G1	Malignant	N
F8	53	50	F	Uterus	Adenocarcinoma	1--2	T1bN0M0	IB	Malignant	N
F9	54	50	F	Uterus	Clear cell carcinoma of endometrium	-	T2bN0M0	IIB	Malignant	N
G1	55	36	F	Uterine cervix	Squamous cell carcinoma	*	T1bN0M0	IB	Malignant	N
G2	56	49	F	Uterine cervix	Squamous cell carcinoma	2	T2N0M0	II	Malignant	N
G3	57	20	F	Striated muscle	Embryonal rhabdomyosarcom of left leg	*	T1aN0M0	IA	Malignant	N
G4	58	70	F	Rectum	Malignant melanoma	*	T4N0M0	IIIB	Malignant	N
G5	59	61	M	Skin	Basal cell carcinoma of left face	*	T2N0M0	II	Malignant	N
G6	60	64	M	Skin	Squamous cell carcinoma of chest wall	2	T3N0M0	II	Malignant	N
G7	61	59	M	Back	Neurofibroma	*	*	*	Malignant	N
G8	62	1	F	Retroperitoneum	Neuroblastoma	*	T2bN0M0	IIIB	Malignant	N
G9	63	60	M	Abdominal cavity	Malignant mesothelioma	*	T2N0M0	IIB G2	Malignant	N
H1	64	49	M	Mediastinum	Diffuse B-cell lymphoma of lymph node	*	*	*	Malignant	N
H2	65	50	F	Lymph node	Diffuse B cell lymphoma of right thigh	*	*	*	Malignant	N
H3	66	27	M	Lymph node	Hodgkin's lymphoma of left groin	*	*	*	Malignant	N
H4	67	19	F	Pelvic cavity	Anaplastic large cell lymphoma	*	*	*	Malignant	N
H5	68	76	M	Bladder	Transitional cell carcinoma	2	T3aN0M0	III	Malignant	N
H6	69	62	M	Bladder	Low grade malignant leiomyosarcoma	*	T2bN0M0	IB G1	Malignant	N
H7	70	7	F	Bone	Osteosarcoma of right femur	*	T2N0M0	IIIB	Malignant	N
H8	71	48	F	Retroperitoneum	Spindle cell rhabdomyosarcoma	*	T2N0M0	IIB	Malignant	N
H9	72	60	F	Smooth muscle	Moderate malignant leiomyosarcoma of left buttock	*	T2bN0M0	IIIB G3	Malignant	N
Tissue Marker